Merck to Close Plant, Build Biologics Research Facility


Aug 06, 2013

Merck said it will close its Kenilworth, NJ manufacturing operation (the former Schering-Plough campus) and lay off 113 employees. The facility will evolve into a research center, focused on discovering and developing biologics.

Hit hard by plunging sales this year, Merck continues to suffer from the patent loss of blockbuster drugs such as Singulair. Read more
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments